市場調査レポート

商品コード

1747278

予防医療市場：サービスタイプ別、疾患領域別、年齢層別、提供形態別、エンドユーザー別、地域別

Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography

出版日: 2025年05月16日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 654,390円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,017,940円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,454,200円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.42円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の予防医療市場は、2025年には4億3,940万米ドルと推定され、2032年には6億3,070万米ドルに達すると予測され、2025年から2032年にかけてCAGR5.3％で成長すると予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	4億3,940万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	5.30%	2032年の価値予測	6億3,070万米ドル

世界の予防医療市場は、疾病予防と早期発見の重要性に対する意識の高まりにより、近年著しい成長を遂げています。予防医療は、疾病の発生を予防し、全体的な健康と幸福を促進するために講じられる事前対策に焦点を当てています。このアプローチには、健康診断、予防接種、生活習慣の改善、リスク評価など、幅広い戦略が含まれます。市場の成長は、慢性疾患の有病率の上昇、高齢者人口の増加、ヘルスケアコストの削減重視の高まりなど、いくつかの要因に起因しています。さらに、診断ツールの技術的進歩や革新的な予防療法の開発が、市場の拡大に拍車をかけています。世界中の政府やヘルスケア機関が予防医療の長期的なメリットを認識していることから、予防医療ソリューションの需要は今後も上昇基調を維持すると予想されます。

市場力学：.

世界の予防医療市場は、いくつかの主要促進要因、市場抑制要因、および市場機会の影響を受けています。主な促進要因の1つは、心血管障害、糖尿病、がんなどの慢性疾患の有病率の増加です。これらの疾病の負担が増加していることから、早期発見と予防が重視されるようになり、予防医療ソリューションの需要に拍車がかかっています。さらに、高齢者は慢性疾患にかかりやすく、定期的な予防医療が必要となるため、世界の高齢者人口の増加が市場の成長をさらに加速させています。しかし、市場には、予防医療技術に関連する高コストや、地域によっては予防医療のメリットに対する認識が低いといった抑制要因もあります。

さらに、国によっては予防医療サービスに対する償還政策が限定的であることも、市場の成長を阻害する可能性があります。こうした課題にもかかわらず、市場には成長とイノベーションの大きな機会があります。ウェアラブルデバイスや遠隔医療などのデジタルヘルス技術の採用が進むことで、遠隔モニタリングや個別化予防医療に新たな道が開けています。さらに、遺伝子検査やバイオマーカー分析などの高度な診断ツールの開発により、より正確なリスク評価と的を絞った予防介入が可能となっています。政府やヘルスケア機関が予防医療を優先し、予防医療イニシアティブにリソースを割り当て続けていることから、市場は今後数年間で大きく成長するものと思われます。

本調査の主な特徴

本レポートでは、世界の予防医療市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（USD Mn）および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の予防医療市場の主要企業をプロファイルしています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界の予防医療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の予防薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 630.7 Mn

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preventive medicine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preventive medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, AstraZeneca, Bayer AG, Becton, Dickinson and Company (BD), bioMerieux, Bristol Myers Squibb, Danaher Corporation, GlaxoSmithKline (GSK), Merck & Co Inc, Novartis, Pfizer, Roche Holding AG, Sanofi, Siemens Healthineers, and Quest Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preventive medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive medicine market

Market Segmentation

Service Type Insights
- Screening & Early Detection
- Vaccination & Immunizatio
- Preventive Drug Therapies
- Wellness & Lifestyle Interventions
- Digital Health & Remote Monitoring Services
Disease Area Insights
- Cardiovascular Diseases
- Cancer
- Diabetes
- Infectious Diseases
- Respiratory Diseases
- Mental Health
- Neurological Disorders
- Osteoporosis
- Others
Age Group Insights
- Pediatric
- Adult
- Geriatric
Mode of Delivery Insights
- On-site/In-Person Delivery
- Remote/Virtual Delivery
End User Insights
- Hospitals & Clinics
- Diagnostic Centers
- Government Organizations
- Private Healthcare Providers
- Employers
- Individuals (Self-Care)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott Laboratories
- AstraZeneca
- Bayer AG
- Becton, Dickinson and Company (BD)
- bioMerieux
- Bristol Myers Squibb
- Danaher Corporation
- GlaxoSmithKline (GSK)
- Merck & Co Inc
- Novartis
- Pfizer
- Roche Holding AG
- Sanofi
- Siemens Healthineers
- Quest Diagnostics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preventive Medicine Market, By Service Type
- Global Preventive Medicine Market, By Disease Area
- Global Preventive Medicine Market, By Age Group
- Global Preventive Medicine Market, By Mode of Delivery
- Global Preventive Medicine Market, By End User
- Global Preventive Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Screening & Early Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccination & Immunization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Preventive Drug Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Wellness & Lifestyle Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Digital Health & Remote Monitoring Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-site/In-Person Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Remote/Virtual Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Employers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Individuals (Self-Care)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

予防医療市場：サービスタイプ別、疾患領域別、年齢層別、提供形態別、エンドユーザー別、地域別

Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の予防医療市場、サービスタイプ別、2020年～2032年

第5章世界の予防医療市場、疾患領域別、2020年～2032年

第6章世界の予防医療市場、年齢別、2020年～2032年

第7章世界の予防医療市場、投与方法別、2020年～2032年

第8章世界の予防医療市場、エンドユーザー別、2020年～2032年

第9章世界の予防医療市場、地域別、2020年～2032年、価値

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

予防医療市場：サービスタイプ別、疾患領域別、年齢層別、提供形態別、エンドユーザー別、地域別

Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の予防医療市場、サービスタイプ別、2020年～2032年

第5章 世界の予防医療市場、疾患領域別、2020年～2032年

第6章 世界の予防医療市場、年齢別、2020年～2032年

第7章 世界の予防医療市場、投与方法別、2020年～2032年

第8章 世界の予防医療市場、エンドユーザー別、2020年～2032年

第9章 世界の予防医療市場、地域別、2020年～2032年、価値

第10章 競合情勢

第11章 アナリストの推奨事項

第12章 参考文献と調査手法

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の予防医療市場、サービスタイプ別、2020年～2032年

第5章世界の予防医療市場、疾患領域別、2020年～2032年

第6章世界の予防医療市場、年齢別、2020年～2032年

第7章世界の予防医療市場、投与方法別、2020年～2032年

第8章世界の予防医療市場、エンドユーザー別、2020年～2032年

第9章世界の予防医療市場、地域別、2020年～2032年、価値

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法